Acelyrin Analyst Ratings
Analysts Offer Insights on Healthcare Companies: ACELYRIN, INC. (SLRN), Arrowhead Pharmaceuticals (ARWR) and NovoCure (NVCR)
Analysts Offer Insights on Healthcare Companies: Poseida Therapeutics (PSTX), Greenwich LifeSciences (GLSI) and ACELYRIN, INC. (SLRN)
Acelyrin Analyst Ratings
Acelyrin Analyst Ratings
Buy Rating Affirmed for ACELYRIN, INC. on Solid Financials and Promising Pipeline
Acelyrin Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Phathom Pharmaceuticals (PHAT), ACELYRIN, INC. (SLRN) and Moderna (MRNA)
Analysts Conflicted on These Healthcare Names: Moderna (MRNA) and ACELYRIN, INC. (SLRN)
Acelyrin Analyst Ratings
ACELYRIN, INC.: Promising Clinical Trials and Market Opportunity Justify Buy Rating
Analysts Conflicted on These Healthcare Names: Inspire Medical Systems (INSP), ACELYRIN, INC. (SLRN) and Vera Therapeutics (VERA)
Acelyrin Analyst Ratings
Buy Rating on ACELYRIN, INC.: Promising Clinical Prospects for Novel TED Therapy Lonigutamab
Analysts Are Bullish on Top Healthcare Stocks: ACELYRIN, INC. (SLRN), ZyVersa Therapeutics (ZVSA)
Acelyrin Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), ACELYRIN, INC. (SLRN) and Geron (GERN)
Hold Rating Affirmed for ACELYRIN, INC. as Izokibep Faces Competitive Hurdles and Safety Concerns
Hold Rating on ACELYRIN, INC. Amidst Clinical Trials and Risk/Reward Analysis
ACELYRIN, INC. (SLRN) Receives a Buy From Piper Sandler